Meyer Children's Hospital IRCCS
Early diagnosis of type 1 diabetes and celiac disease is very useful, allows early therapy and prevents deaths from the onset of diabetic ketoacidosis. This is a pilot study on screening of autoantibodies of type 1 diabetes and celiac disease in tuscany patients. The study aims to evaluate the concordance between the screening results obtained using two different matrix (blood drop spots on card and serum) in the search for autoantibodies for celiac disease and for type 1 diabetes. Moreover, it will be evaluated the feasibility and acceptability of the screening on a sample of the population enrolled in the territory through the participation of pediatricians.
Celiac Disease in Children
Diabetes Mellitus, Type I
Screening
Test on blood sample
Test on dried blood sample
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 1500 participants |
| Masking : | NONE |
| Primary Purpose : | DIAGNOSTIC |
| Official Title : | Auto-antibody Dosage From Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease |
| Actual Study Start Date : | 2024-11-04 |
| Estimated Primary Completion Date : | 2026-03-30 |
| Estimated Study Completion Date : | 2026-03-30 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 2 Years to 13 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Meyer Children's Hospital IRCCS
Florence, Italy, Italy, 50139